Corrigendum to: Molecular Characterization of Carbamoyl-Phosphate Synthetase (CPS1) Deficiency Using Human Recombinant CPS1 as a Key Tool (Human Mutation, (2013), 34, 8, (1149-1159), 10.1002/humu.22349);Molecular characterization of carbamoyl-phosphate synthetase (CPS1) deficiency using human recombinant CPS1 as a key tool

Human Mutation

Volumn 34, Issue 8, 2013, Pages 1149-1159

  Diez Fernandez, Carmen ^a,b   Martínez, Ana I ^b   Pekkala, Satu ^b,e   Barcelona, Belén ^a,b,c   Pérez Arellano, Isabel ^b,c   Guadalajara, Ana María ^b   Summar, Marshall ^d   Cervera, Javier ^a,b,c   Rubio, Vicente ^a,c  

^a INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF JYVÄSKYLÄ   (Finland)

Author keywords

Carbamylglutamate; CPS1 deficiency; Hyperammonemia; Urea cycle

Indexed keywords

CARBAMOYL PHOSPHATE SYNTHASE; CHAPERONE; GLUTAMATE ACETYLTRANSFERASE; GLYCEROL; MYOSIN ADENOSINE TRIPHOSPHATASE; ORPHAN DRUG; RECOMBINANT ENZYME;

ANIMAL TISSUE; ARTICLE; CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY; CATALYSIS; CLINICAL ARTICLE; DNA POLYMORPHISM; ENZYME STABILITY; GENE MUTATION; HUMAN; HYPERAMMONEMIA; MISSENSE MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; THERMAL ANALYSIS; UREA CYCLE;

EID: 84880514583     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.23710     Document Type: Erratum

References (53)

1. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. 2010. A method and server for predicting damaging missense mutations. Nat Methods 7:248-249.
2. Ahuja V, Powers-Lee SG. 2008. Human carbamoyl-phosphate synthetase: insight into N-acetylglutamate interaction and the functional effects of a common single nucleotide polymorphism. J Inherit Metab Dis 31:481-491.
3. Alonso E, Cervera J, García-España A, Bendala E, Rubio V. 1992. Oxidative inactivation of carbamoyl phosphate synthetase (ammonia). Mechanism and sites of oxidation, degradation of the oxidized enzyme, and inactivation by glycerol, EDTA, and thiol protecting agents. J Biol Chem 267:4524-4532.
4. Alonso E, Girbés J, García-España A, Rubio V. 1989. Changes in urea cycle-related metabolites in the mouse after combined administration of valproic acid and an amino acid load. Arch Biochem Biophys 272:267-273.
5. Alonso E, Rubio V. 1983. Binding of N-acetyl-L-glutamate to rat liver carbamoyl phosphate synthetase (ammonia). Eur J Biochem 135:331-337.
6. Amero SA, James TC, Elgin SC. 1994. Production of antibodies using proteins in gel bands. Methods Mol Biol 32:401-406.
7. Barcelona-Andrés B, Marina A, Rubio V. 2002. Gene structure, organization, expression, and potential regulatory mechanisms of arginine catabolism in Enterococcus faecalis. J Bacteriol 184:6289-6300.
8. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
9. Britton HG, Rubio V, Grisolia S. 1981. Synthesis of carbamoyl phosphate by carbamoyl phosphate synthetase I in the absence of acetylglutamate. Activation of the enzyme by cryoprotectants. Biochem Biophys Res Commun 99:1131-1137.
10. Brusilow SW, Horwich AL. 2001. Urea cycle enzymes. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors; Child B, Kinzler KW, Vogelstein B, associated editors. The metabolic and molecular bases of inherited disease, 8e. New York: McGraw-Hill. Vol 2, p 1909-1963.
11. Carrey EA, Campbell DG, Hardie DG. 1985. Phosphorylation and activation of hamster carbamyl phosphate synthetase II by cAMP-dependent protein kinase. A novel mechanism for regulation of pyrimidine nucleotide biosynthesis. EMBO J 4:3735-3742.
12. Cervera J, Conejero-Lara F, Ruiz-Sanz J, Galisteo ML, Mateo PL, Lusty CJ, Rubio V. 1993. The influence of effectors and subunit interactions on Escherichia coli carbamoyl-phosphate synthetase studied by differential scanning calorimetry. J Biol Chem 268:12504-12511.
13. Eeds AM, Hall LD, Yadav M, Willis A, Summar S, Putnam A, Barr F, Summar ML. 2006. The frequent observation of evidence for nonsense-mediated decay in RNA from patients with carbamyl phosphate synthetase I deficiency. Mol Genet Metab 89:80-86.
14. Erlandsen H, Pey AL, Gámez A, Pérez B, Desviat LR, Aguado C, Koch R, Surendran S, Tyring S, Matalon R, Scriver CR, Ugarte M, et al. 2004 Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations. Proc Natl Acad Sci USA 101:16903-16908.
15. Evans DR, Balon MA. 1988. Controlled proteolysis of ammonia-dependent carbamoyl-phosphate synthetase I from Syrian hamster liver. Biochim Biophys Acta 953: 185-196.
16. Finckh U, Kohlschutter A, Schafer H, Sperhake K, Colombo JP, Gal A. 1998. Prenatal diagnosis of carbamoyl-phosphate synthetase I deficiency by identification of a missense mutation in CPS1. Hum Mutat 12:206-211.
17. Guadalajara AM, Rubio V, Grisolía S. 1983. Inactivation of carbamoyl phosphate synthetase (ammonia) by elastase as a probe to investigate binding of the substrates. Biochem Biophys Res Commun 117:238-244.
18. Guthöhrlein G, Knappe J. 1968. Structure and function of carbamoylphosphate synthase. I. Transitions between two catalytically inactive forms and the active form. Eur J Biochem 7:119-127.
19. Häberle J, Boddaert N, Burlina A, Chakrapani A, Dixon M, Huemer M, Karall D, Martinelli D, Sanjurjo Crespo P, Santer R, Servais A, et al. 2012. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis 7:32.
20. Häberle J, Shchelochkov OA, Wang J, Katsonis P, Hall L, Reiss S, Eeds A, Willis A, Yadav M, Summar S; Urea Cycle Disorders Consortium, Lichtarge O, et al. 2011. Molecular defects in human carbamoyl phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations. Hum Mutat 32:579-585.
21. Haraguchi Y, Uchino T, Takiguchi M, Endo F, Mori M, Matsuda I. 1991. Cloning and sequence of a cDNA encoding human carbamyl phosphate synthetase I: molecular analysis of hyperammonemia. Gene 107:335-340.
22. Kurokawa K, Yorifuji T, Kawai M, Momoi T, Nagasaka H, Takayanagi M, Kobayashi K, Yoshino M, Kosho T, Adachi M, Otsuka H, Yamamoto S, et al. 2007. Molecular and clinical analyses of Japanese patients with carbamoylphosphate synthetase 1 (CPS1) deficiency. J Hum Genet 52:349-354.
23. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
24. Li B, Krishnan VG, Mort ME, Xin F, Kamati KK, Cooper DN, Mooney SD, Radivojac P. 2009. Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics 25:2744-2750.
25. Liu X, Guy HI, Evans DR. 1994. Identification of the regulatory domain of the mammalian multifunctional protein CAD by the construction of an Escherichia coli hamster hybrid carbamyl-phosphate synthetase. J Biol Chem 269:27747-27755.
26. Marshall M, Cohen PP. 1972. Ornithine transcarbamylase from Streptococcus faecalis and bovine liver. I. Isolation and subunit structure. J Biol Chem 247:1641-1653.
27. Marshall M, Fahien LA. 1985. Proximate sulfhydryl groups in the acetylglutamate complex of rat carbamylphosphate synthetase I: their reaction with the affinity reagent 5′-p-fluorosulfonylbenzoyladenosine. Arch Biochem Biophys 241:200-214.
28. Marshall M, Fahien LA. 1988. Proteolysis as a probe of ligand-associated conformational changes in rat carbamyl phosphate synthetase I. Arch Biochem Biophys 262:455-470.
29. Martínez AI, Pérez-Arellano I, Pekkala S, Barcelona B, Cervera J. 2010. Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency. Mol Genet Metab 101:311-323.
30. Meister A. 1989. Mechanism and regulation of the glutamine-dependent carbamyl phosphate synthetase of Escherichia coli. Adv Enzymol Relat Areas Mol Biol 62:315-374.
31. Metzenberg RL, Marshall M, Cohen PP. 1958. Carbamyl phosphate synthetase: studies on the mechanism of action. J Biol Chem 233:1560-1564.
32. Nyunoya H, Broglie KE, Widgren EE, Lusty CJ. 1985. Characterization and derivation of the gene coding for mitochondrial carbamyl phosphate synthetase I of rat. J Biol Chem 260:9346-9356.
33. Pearson DL, Dawling S, Walsh WF, Haines JL, Christman BW, Bazyk A, Scott N, Summar ML. 2001. Neonatal pulmonary hypertension-urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N Engl J Med 344:1832-1838.
34. Pekkala S, Martinez AI, Barcelona B, Gallego J, Bendala E, Yefimenko I, Rubio V, Cervera J. 2009. Structural insight on the control of urea synthesis: identification of the binding site for N-acetyl-l-glutamate, the essential allosteric activator of mitochondrial carbamoyl-phosphate synthetase1. Biochem J 424:211-220.
35. Pekkala S, Martínez AI, Barcelona B, Yefimenko I, Finckh U, Rubio V, Cervera J. 2010. Understanding carbamoyl-phosphate synthetase I (CPS1) deficiency by using expression studies and structure-based analysis. Hum Mutat 31:801-808.
36. Pierson DL, Brien JM. 1980. Human carbamylphosphate synthetase I. Stabilization, purification, and partial characterization of the enzyme from human liver. J Biol Chem 255:7891-7895.
37. Powers-Lee SG, Corina K. 1986. Domain structure of rat liver carbamoyl phosphate synthetase I. J Biol Chem 261:15349-15352.
38. Raijman L, Jones ME. 1976. Purification, composition, and some properties of rat liver carbamyl phosphate synthetase (ammonia). Arch Biochem Biophys 175:270-278.
39. Rodríguez-Aparicio LB, Guadalajara AM, Rubio V. 1989. Physical location of the site for N-acetyl-l-glutamate, the allosteric activator of carbamoyl phosphate synthetase, in the 20-kilodalton COOH-terminal domain. Biochemistry 28:3070-3074.
40. Rubio V, Britton HG, Grisolia S. 1983a. Mitochondrial carbamoyl phosphate synthetase activity in the absence of N-acetyl-l-glutamate. Mechanism of activation by this cofactor. Eur J Biochem 134:337-343.
41. Rubio V, Britton HG, Grisolía S. 1983b. Activation of carbamoyl phosphate synthetase by cryoprotectants. Mol Cell Biochem 53-54:279-298.
42. Rubio V, Cervera J, Lusty CJ, Bendala E, Britton HG. 1991. Domain structure of the large subunit of Escherichia coli carbamoyl phosphate synthetase. Location of the binding site for the allosteric inhibitor UMP in the COOH-terminal domain. Biochemistry 30:1068-1075.
43. Rubio V, Ramponi G, Grisolia S. 1981. Carbamoyl-phosphate synthetase I of human liver. Purification, some properties and immunological cross-reactivity with the rat liver enzyme. Biochim Biophys Acta 659:150-160.
44. Rubio V. 1993. Structure-function studies in carbamoyl phosphate synthetases. Biochem Soc Trans 21:198-202.
45. Ryall J, Nguyen M, Bendayan M, Shore GC. 1985. Expression of nuclear genes encoding the urea cycle enzymes, carbamoyl-phosphate synthetase I and ornithine carbamoyl transferase, in rat liver and intestinal mucosa. Eur J Biochem 152:287-292.
46. Shih VE. 1976 Congenital hyperammonemic syndromes. Clin Perinatol 3:3-14.
47. Simmer JP, Kelly RE, Rinker AG Jr, Scully JL, Evans DR. 1990. Mammalian carbamyl phosphate synthetase (CPS). DNA sequence and evolution of the CPS domain of the Syrian hamster multifunctional protein CAD. J Biol Chem 265:10395-10402.
48. Summar ML, Dasouki MJ, Schofield PJ, Krishnamani MR, Vnencak-Jones C, Tuchman M, Mao J, Phillips JA 3rd. 1995. Physical and linkage mapping of human carbamyl phosphate synthetase I (CPS1) and reassignment from 2p to 2q35. Cytogenet Cell Genet 71:266-267.
49. Summar ML, Hall LD, Eeds AM, Hutcheson HB, Kuo AN, Willis AS, Rubio V, Arvin MK, Schofield JP, Dawson EP. 2003. Characterization of genomic structure and polymorphisms in the human carbamyl phosphate synthetase I gene. Gene 311:51-57.
50. Summar ML. 1998. Molecular genetic research into carbamoyl-phosphate synthase I: molecular defects and linkage markers. J Inherit Metab Dis 21 Suppl 1:30-39.
51. Thoden JB, Holden HM, Wesenberg G, Raushel FM, Rayment I. 1997. Structure of carbamoyl phosphate synthetase: a journey of 96 Å from substrate to product. Biochemistry 36:6305-6316.
52. Williams M, Huijmans JGM, van Diggelen OP, van der Low EJTM, de Klerk JBC, Haeberle J. 2010. Carbamoyl phosphate synthetase I (CPS 1) deficiency: treatment with carglumic acid (Carbaglu) J Inherit Metab Dis 33(Suppl 1):S118.
53. Yefimenko I, Fresquet V, Marco-Marín C, Rubio V, Cervera J. 2005. Understanding carbamoyl-phosphate synthetase deficiency: impact of clinical mutations on enzyme functionality. J Mol Biol 349:127-141.